We Think Shareholders Are Less Likely To Approve A Pay Rise For ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) CEO For Now
We Think Shareholders Are Less Likely To Approve A Pay Rise For ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) CEO For Now
Key Insights
关键见解
- ClearPoint Neuro to hold its Annual General Meeting on 15th of May
- Total pay for CEO Joe Burnett includes US$517.7k salary
- The overall pay is comparable to the industry average
- Over the past three years, ClearPoint Neuro's EPS fell by 18% and over the past three years, the total loss to shareholders 66%
- ClearPoint Neuro将于5月15日举行年度股东大会
- 首席执行官乔·伯内特的总薪水包括517.7万美元的工资
- 总体薪酬与行业平均水平相当
- 在过去三年中,ClearPoint Neuro的每股收益下降了18%,在过去三年中,股东的总亏损为66%
In the past three years, the share price of ClearPoint Neuro, Inc. (NASDAQ:CLPT) has struggled to grow and now shareholders are sitting on a loss. Per share earnings growth is also lacking, despite revenue growth. The AGM coming up on 15th of May will be an opportunity for shareholders to have their concerns addressed by the board and for them to exercise their influence on management through voting on resolutions such as executive remuneration. Here's why we think shareholders should hold off on a raise for the CEO at the moment.
在过去的三年中,ClearPoint Neuro, Inc.(纳斯达克股票代码:CLPT)的股价一直难以增长,现在股东们处于亏损状态。尽管收入增长,但每股收益也缺乏增长。即将于5月15日举行的股东周年大会将为股东提供一个机会,使他们有机会让董事会解决他们的担忧,并通过对高管薪酬等决议进行表决,对管理层施加影响。这就是为什么我们认为股东目前应该推迟对首席执行官的加薪。
Comparing ClearPoint Neuro, Inc.'s CEO Compensation With The Industry
比较 ClearPoint Neuro, Inc.”s 首席执行官向业界提供的薪酬
According to our data, ClearPoint Neuro, Inc. has a market capitalization of US$164m, and paid its CEO total annual compensation worth US$2.0m over the year to December 2023. We note that's a small decrease of 6.3% on last year. We think total compensation is more important but our data shows that the CEO salary is lower, at US$518k.
根据我们的数据,ClearPoint Neuro, Inc.的市值为1.64亿美元,在截至2023年12月的一年中,向其首席执行官支付的年薪总额为200万美元。我们注意到这比去年小幅下降了6.3%。我们认为总薪酬更为重要,但我们的数据显示,首席执行官的薪水较低,为51.8万美元。
On comparing similar companies from the American Medical Equipment industry with market caps ranging from US$100m to US$400m, we found that the median CEO total compensation was US$1.8m. So it looks like ClearPoint Neuro compensates Joe Burnett in line with the median for the industry. Furthermore, Joe Burnett directly owns US$1.6m worth of shares in the company, implying that they are deeply invested in the company's success.
在比较市值从1亿美元到4亿美元不等的美国医疗设备行业的类似公司时,我们发现首席执行官的总薪酬中位数为180万美元。因此,看来ClearPoint Neuro对乔·伯内特的补偿与该行业的中位数一致。此外,乔·伯内特直接拥有该公司价值160万美元的股份,这意味着他们对公司的成功进行了大量投资。
Component | 2023 | 2022 | Proportion (2023) |
Salary | US$518k | US$494k | 26% |
Other | US$1.5m | US$1.6m | 74% |
Total Compensation | US$2.0m | US$2.1m | 100% |
组件 | 2023 | 2022 | 比例 (2023) |
工资 | 518k 美元 | 494k 美元 | 26% |
其他 | 150 万美元 | 160 万美元 | 74% |
总薪酬 | 200 万美元 | 2.1 万美元 | 100% |
On an industry level, around 25% of total compensation represents salary and 75% is other remuneration. Although there is a difference in how total compensation is set, ClearPoint Neuro more or less reflects the market in terms of setting the salary. It's important to note that a slant towards non-salary compensation suggests that total pay is tied to the company's performance.
在行业层面上,总薪酬中约有25%代表工资,75%是其他薪酬。尽管总薪酬的设定方式有所不同,但ClearPoint Neuro在设定工资方面或多或少地反映了市场。值得注意的是,对非工资薪酬的倾向表明,总薪酬与公司的业绩挂钩。
![ceo-compensation](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240509/0-6dbafad54654f184f6b5a9588619f4c4-0-e74842ec11842bf4f6d0f32ec4e11525.png/big)
ClearPoint Neuro, Inc.'s Growth
ClearPoint Neuro, Inc.s 增长
Over the last three years, ClearPoint Neuro, Inc. has shrunk its earnings per share by 18% per year. It achieved revenue growth of 25% over the last year.
在过去的三年中,ClearPoint Neuro, Inc.的每股收益每年缩水18%。去年,它实现了25%的收入增长。
Investors would be a bit wary of companies that have lower EPS On the other hand, the strong revenue growth suggests the business is growing. These two metrics are moving in different directions, so while it's hard to be confident judging performance, we think the stock is worth watching. Looking ahead, you might want to check this free visual report on analyst forecasts for the company's future earnings..
投资者会对每股收益较低的公司保持警惕。另一方面,强劲的收入增长表明业务正在增长。这两个指标正朝着不同的方向发展,因此,尽管很难自信地判断表现,但我们认为该股值得关注。展望未来,您可能需要查看这份关于分析师对公司未来收益预测的免费可视化报告。
Has ClearPoint Neuro, Inc. Been A Good Investment?
ClearPoint Neuro, Inc. 是一项不错的投资吗?
The return of -66% over three years would not have pleased ClearPoint Neuro, Inc. shareholders. So shareholders would probably want the company to be less generous with CEO compensation.
三年内-66%的回报率不会让ClearPoint Neuro, Inc.的股东感到高兴。因此,股东们可能希望公司在首席执行官薪酬方面不那么慷慨。
In Summary...
总而言之...
The loss to shareholders over the past three years is certainly concerning and possibly has something to do with the fact that the company's earnings haven't grown. In the upcoming AGM, shareholders will get the opportunity to discuss any issues with the board, including those related to CEO remuneration and assess if the board's plan is in line with their expectations.
过去三年的股东损失无疑令人担忧,可能与公司收益没有增长这一事实有关。在即将举行的股东周年大会上,股东将有机会与董事会讨论任何问题,包括与首席执行官薪酬有关的问题,并评估董事会的计划是否符合他们的预期。
While CEO pay is an important factor to be aware of, there are other areas that investors should be mindful of as well. That's why we did some digging and identified 2 warning signs for ClearPoint Neuro that investors should think about before committing capital to this stock.
尽管首席执行官的薪酬是一个需要注意的重要因素,但投资者还应注意其他领域。这就是为什么我们进行了一些挖掘并确定了ClearPoint Neuro的两个警告信号,投资者在向该股票投入资金之前应考虑这些信号。
Of course, you might find a fantastic investment by looking at a different set of stocks. So take a peek at this free list of interesting companies.
当然,通过查看另一组股票,你可能会找到一笔不错的投资。因此,来看看这份有趣的公司的免费清单吧。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。